Rapid Micro Biosystems (RPID) Cash from Financing Activities (2020 - 2025)
Rapid Micro Biosystems' Cash from Financing Activities history spans 6 years, with the latest figure at $443000.0 for Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 7483.33% to $443000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $19.8 million, a 9639.41% increase, with the full-year FY2025 number at $19.8 million, up 9639.41% from a year prior.
- Cash from Financing Activities hit $443000.0 in Q4 2025 for Rapid Micro Biosystems, down from $19.2 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for RPID hit a ceiling of $139.3 million in Q3 2021 and a floor of -$1.4 million in Q2 2021.
- Historically, Cash from Financing Activities has averaged $11.9 million across 5 years, with a median of $74000.0 in 2022.
- Biggest five-year swings in Cash from Financing Activities: skyrocketed 2786080.0% in 2021 and later tumbled 2880.0% in 2025.
- Tracing RPID's Cash from Financing Activities over 5 years: stood at -$1.3 million in 2021, then soared by 106.93% to $87000.0 in 2022, then crashed by 113.79% to -$12000.0 in 2023, then soared by 50.0% to -$6000.0 in 2024, then skyrocketed by 7483.33% to $443000.0 in 2025.
- Business Quant data shows Cash from Financing Activities for RPID at $443000.0 in Q4 2025, $19.2 million in Q3 2025, and -$298000.0 in Q2 2025.